Literature DB >> 18165172

Glucocorticoid receptor beta splice variant expression in patients with high and low activity of systemic lupus erythematosus.

Piotr Piotrowski1, Michal Burzynski, Margarita Lianeri, Magdalenaa Mostowska, Mariusz Wudarski, Hanna Chwalinska-Sadowska, Pawel P Jagodzinski.   

Abstract

The glucocorticoid receptor (GR) occurs mainly in two alternative splice variants encoding GRalpha and GRbeta. The GRbeta variant does not contain a GC binding domain and cannot mediate anti-inflammatory GC effects. Peripheral blood mononuclear cells (PBMCs) were isolated from venous whole blood of twelve patients with SLE. Ten of the SLE patients exhibited low disease activity while two patients displayed highly active stage of the disease. The quantitative analysis of GRalpha and GRbeta transcripts in PBMC was performed by reverse transcription and real-time quantitative PCR SYBR Green I system. The protein level of GRalpha and GRbeta isoforms in PBMCs was determined by western blotting analysis. We found that the two SLE patients with high disease activity exhibited significantly elevated GRbeta transcript levels and corresponding protein levels in PBMCs. These preliminary findings suggest that increased expression of GRbeta isoform may be associated with relatively more severe clinical presentation of SLE syndrome.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18165172

Source DB:  PubMed          Journal:  Folia Histochem Cytobiol        ISSN: 0239-8508            Impact factor:   1.698


  19 in total

Review 1.  Glucocorticoid receptor: implications for rheumatic diseases.

Authors:  T Kino; E Charmandari; G P Chrousos
Journal:  Clin Exp Rheumatol       Date:  2011-10-21       Impact factor: 4.473

Review 2.  Tissue-specific glucocorticoid action: a family affair.

Authors:  Katherine L Gross; John A Cidlowski
Journal:  Trends Endocrinol Metab       Date:  2008-09-19       Impact factor: 12.015

Review 3.  The Interactome of the Glucocorticoid Receptor and Its Influence on the Actions of Glucocorticoids in Combatting Inflammatory and Infectious Diseases.

Authors:  Ioanna Petta; Lien Dejager; Marlies Ballegeer; Sam Lievens; Jan Tavernier; Karolien De Bosscher; Claude Libert
Journal:  Microbiol Mol Biol Rev       Date:  2016-05-11       Impact factor: 11.056

4.  The risk benefit ratio of glucocorticoids in SLE: have things changed over the past 40 years?

Authors:  G Stojan; M Petri
Journal:  Curr Treatm Opt Rheumatol       Date:  2017-07-27

5.  Hypermethylation of glucocorticoid receptor gene promoter results in glucocorticoid receptor gene low expression in peripheral blood mononuclear cells of patients with systemic lupus erythematosus.

Authors:  Hongbo Chen; Junfen Fan; Qiyang Shou; Lizong Zhang; Hongzhen Ma; Yongsheng Fan
Journal:  Rheumatol Int       Date:  2015-04-22       Impact factor: 2.631

Review 6.  DNA methylation in systemic lupus erythematosus.

Authors:  Christian M Hedrich; Katrin Mäbert; Thomas Rauen; George C Tsokos
Journal:  Epigenomics       Date:  2016-11-25       Impact factor: 4.778

7.  Glucocorticoid receptor β stimulates Akt1 growth pathway by attenuation of PTEN.

Authors:  Lance A Stechschulte; Leah Wuescher; Joseph S Marino; Jennifer W Hill; Charis Eng; Terry D Hinds
Journal:  J Biol Chem       Date:  2014-05-09       Impact factor: 5.157

8.  Evidence for a glucocorticoid receptor beta splice variant in the rat and its physiological regulation in liver.

Authors:  Debra C DuBois; Siddharth Sukumaran; William J Jusko; Richard R Almon
Journal:  Steroids       Date:  2012-12-19       Impact factor: 2.668

Review 9.  Naturally occurring C-terminal splice variants of nuclear receptors.

Authors:  Michiel van der Vaart; Marcel J M Schaaf
Journal:  Nucl Recept Signal       Date:  2009-06-19

10.  The role of glucocorticoid receptor (GR) polymorphisms in human erythropoiesis.

Authors:  Lilian Varricchio; Anna Rita Migliaccio
Journal:  Am J Blood Res       Date:  2014-12-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.